Stoke Therapeutics Executives Sell Shares to Cover Tax Liabilities and Other Reasons
Executives at Stoke Therapeutics, including Edward M. Kaye, Barry Ticho, and Allan Jonathan, sold shares to cover tax liabilities. Kaye sold 2,136 shares for $64,541, Ticho sold 4,020 shares for $121,468, and Jonathan sold 4,576 shares for $138,268. These transactions occurred on December 2 and 3, 2025, with prices ranging from $28.93 to $31.17 per share.
TradingView·